Cyteir Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cyteir Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q4 2022.
  • Cyteir Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2022 was $2.07M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $2.07M Dec 31, 2022 10-Q 2023-11-06
Q3 2022 $2.22M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $2.38M Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $2.62M Mar 31, 2022 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.